Results 201 to 210 of about 116,410 (313)

Five Cases of Hepatic Mesenchymal Tumors Diagnosed by Endoscopic Ultrasound‐Guided Tissue Acquisition

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Percutaneous biopsy remains the gold standard for diagnosing focal liver lesions; however, endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) has recently emerged as a promising alternative. Although its diagnostic performance is favorable, most available evidence has focused on epithelial tumors, and reports on mesenchymal tumors are ...
Yuichi Takano   +9 more
wiley   +1 more source

Stepwise Algorithm for Biliary Cannulation in Endoscopic Retrograde Cholangiopancreatography in the Era of Endoscopic Ultrasound‐Guided Biliary Drainage: A Single‐Center Retrospective Cohort Study

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is an essential procedure for the management of biliary diseases. Successful biliary cannulation is the first step. Advanced cannulation techniques, such as the double‐guidewire technique (DGW), precut techniques, and endoscopic ultrasound (EUS)‐guided rendezvous (RV), have ...
Akihiko Senju   +7 more
wiley   +1 more source

The Diagnostic Value of PET/CT and MRI in Head and Neck Cancer of Unknown Primary

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 2, April 2026.
PET/CT demonstrates a higher diagnostic yield than MRI in detecting primary tumors in patients undergoing diagnostic work‐up for head and neck cancer of unknown primary origin. However, combining PET/CT and MRI improves overall detection rates and enhances soft tissue evaluation.
Signe Bergliot Nielsen   +8 more
wiley   +1 more source

Effectiveness of Prophylactic Central Neck Dissection in Intermediate‐Risk Papillary Thyroid Cancer

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 2, April 2026.
This study reveals the effectiveness prophylactic central neck dissection in terms of recurrence‐free survival time and recurrence outcomes in intermediate‐risk papillary thyroid carcinoma patients. The advantage is the large number of studied patients and thus more reliable result of the studied compared to previous studies.
Vipa Rath Marpukdee   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy